Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
2001 1
2004 2
2005 1
2006 1
2007 2
2008 1
2010 3
2011 4
2012 1
2013 5
2014 6
2015 4
2016 4
2017 3
2018 2
2019 3
2020 1
2021 4
2022 6
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for poulikakos p
Search for Poulikarakos P instead (1 results)
Molecular Pathways and Mechanisms of BRAF in Cancer Therapy.
Poulikakos PI, Sullivan RJ, Yaeger R. Poulikakos PI, et al. Clin Cancer Res. 2022 Nov 1;28(21):4618-4628. doi: 10.1158/1078-0432.CCR-21-2138. Clin Cancer Res. 2022. PMID: 35486097 Free PMC article. Review.
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders.
Wu X, Yang X, Xiong Y, Li R, Ito T, Ahmed TA, Karoulia Z, Adamopoulos C, Wang H, Wang L, Xie L, Liu J, Ueberheide B, Aaronson SA, Chen X, Buchanan SG, Sellers WR, Jin J, Poulikakos PI. Wu X, et al. Among authors: poulikakos pi. Nat Cancer. 2021 Apr;2(4):429-443. doi: 10.1038/s43018-021-00174-z. Epub 2021 Mar 1. Nat Cancer. 2021. PMID: 34568836 Free PMC article.
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology.
Bigenwald C, Le Berichel J, Wilk CM, Chakraborty R, Chen ST, Tabachnikova A, Mancusi R, Abhyankar H, Casanova-Acebes M, Laface I, Akturk G, Jobson J, Karoulia Z, Martin JC, Grout J, Rafiei A, Lin H, Manz MG, Baccarini A, Poulikakos PI, Brown BD, Gnjatic S, Lujambio A, McClain KL, Picarsic J, Allen CE, Merad M. Bigenwald C, et al. Among authors: poulikakos pi. Nat Med. 2021 May;27(5):851-861. doi: 10.1038/s41591-021-01304-x. Epub 2021 May 6. Nat Med. 2021. PMID: 33958797 Free PMC article.
Aminoglycoside therapy in infectious diseases.
Poulikakos P, Falagas ME. Poulikakos P, et al. Expert Opin Pharmacother. 2013 Aug;14(12):1585-97. doi: 10.1517/14656566.2013.806486. Epub 2013 Jun 8. Expert Opin Pharmacother. 2013. PMID: 23746121 Review.
Mutant BRAF melanomas--dependence and resistance.
Poulikakos PI, Rosen N. Poulikakos PI, et al. Cancer Cell. 2011 Jan 18;19(1):11-5. doi: 10.1016/j.ccr.2011.01.008. Cancer Cell. 2011. PMID: 21251612 Free article. Review.
CDK4: a master regulator of the cell cycle and its role in cancer.
Baker SJ, Poulikakos PI, Irie HY, Parekh S, Reddy EP. Baker SJ, et al. Among authors: poulikakos pi. Genes Cancer. 2022 Aug 25;13:21-45. doi: 10.18632/genesandcancer.221. eCollection 2022. Genes Cancer. 2022. PMID: 36051751 Free PMC article. Review.
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling.
Adamopoulos C, Ahmed TA, Tucker MR, Ung PMU, Xiao M, Karoulia Z, Amabile A, Wu X, Aaronson SA, Ang C, Rebecca VW, Brown BD, Schlessinger A, Herlyn M, Wang Q, Shaw DE, Poulikakos PI. Adamopoulos C, et al. Among authors: poulikakos pi. Cancer Discov. 2021 Jul;11(7):1716-1735. doi: 10.1158/2159-8290.CD-20-1351. Epub 2021 Feb 10. Cancer Discov. 2021. PMID: 33568355 Free PMC article.
54 results